Skip to main content
. 2019 Dec 30;19:1257. doi: 10.1186/s12885-019-6490-7

Table 2.

Association of the investigated ESR1, ESR2, HER2, UGT1A4, and UGT2B7 SNPs and breast cancer (BC)

Gene SNP ID Allelic and Genotypic Frequencies in Cases and Controls
Allele/Genotype Cases
(n = 218)
Controls
(n = 219)
P-value Chi-square
ESR1 rs2234693 C 222(0.51) 221(0.51) 0.943 0.005
T 216(0.49) 213(0.49)
CC 60 (27.4) 48 (22.1) 0.069 5.328
TC 102 (46.6) 125 (57.6)
TT 57 (26) 44 (20.3)
rs9340799 A 231(0.53) 234(0.54) 0.782 0.076
G 205(0.47) 200 (0.46)
AA 64 (29.4) 54 (24.9) 0.067 5.383
AG 103 (47.2) 126 (58.1)
GG 51 (23.4) 37 (17.1)
rs3020410 C 399(0.9) 399(0.92) 0.387 0.748
A 43(0.1) 35(0.08)
CC 181 (81.9) 184 (84.8) 0.698 0.718
CA 37 (16.7) 31 (14.3)
AA 3 (1.4) 2 (0.9)
rs3798577 T 258(0.59) 224(0.52) 0.024 5.033
C 178(0.41) 210(0.48)
TT 80 (36.7) 56 (25.8) 0.047 6.076
TC 98 (45) 112 (51.6)
CC 40 (18.4) 49 (22.6)
ESR2 rs1256049 C 434(0.98) 425(0.98) 0.777 0.08
T 8(0.02) 9(0.02)
CC 213 (96.4) 208 (95.8) 0.774 0.082
CT 8 (3.6) 9 (4.2)
HER2 rs1058808 G 300(0.68) 296(0.68) N/A N/A
C 140(0.32) 138(0.32)
GG 101 (45.9) 105 (48.4) 0.503 1.372
GC 98 (44.5) 86 (39.6)
CC 21 (9.6) 26 (12)
UGT1A4 rs12468274 T 400(0.92) 402(0.93) 0.627 0.236
C 36 (0.08) 32(0.07)
TT 182 (83.5) 185 (85.2) 0.611 0.258
CT 36 (16.5) 32 (14.8)
rs2011425 T 399(0.91) 392(0.91) 0.974 0.001
G 39(0.09) 38 (0.09)
TT 180 (82.2) 177 (82.3) 0.974 0.001
TG 39 (17.8) 38 (17.7)
rs6755571 C 416(0.94) 413(0.95) 0.694 0.154
A 26(0.06) 23(0.05)
CC 196 (88.7) 197 (90.4) 0.638 0.897
CA 24 (10.9) 19 (8.7)
AA 1 (0.4) 2 (0.9)
UGT2B7 rs28365062 A 371(0.84) 362(0.83) 0.605 0.267
G 69 (0.16) 74(0.17)
AA 159 (72.3) 152 (69.7) 0.829 0.374
GA 53 (24.1) 58 (26.6)
GG 8 (3.6) 8 (3.7)
rs4348159 C 369(0.84) 361(0.83) 0.785 0.074
T 71(0.16) 73(0.17)
CC 158 (71.8%) 152 (70) 0.860 0.3
TC 53 (24.1%) 57 (26.3)
TT 9 (4.1%) 8 (3.7)

P-Value < 0.05 was considered as significant